Read more at BioPharm• August 17, 2023
Category: AbSci
Vancouver biotech to develop Bill Gates-funded HIV treatment with Caltech
Read more at Portland Business Journal• August 10, 2023
Absci and M2GEN partner to expedite cancer drug development
Read more at Pharmaceutical Technology• April 5, 2023
Synthetic biology innovator opens new campus to speed up drug discovery
Read more in BioPharma-Reporter • October 21, 2021
Absci opens door to new biotechnology campus
Read more in GlobeNewswire • October 20, 2021
Absci and EQRx in tie-up to accelerate production of cheaper, protein based therapeutics
Read more in BioPharma • October 6, 2021
EQRx and Absci announce partnership to discover and develop next-generation protein-based drugs
Read more in Yahoo Finance • October 6, 2021
Absci to participate in the BofA Securities 2021 Tech Solutions for drug discovery conference
Read more in Yahoo! Finance • September 13, 2021
AbSci announces acquisition of target discovery company Totient
Read now on prnewswire.com • June 14, 2021
Vancouver-based AbSci wins $125 million from new investors
Read now on columbian.com • March 23, 2021
Columbia Ventures Corporation 